Wednesday, June 2, 2021

Serum Institute of India seeks indemnity against liabilities: Sources

Serum Institute of India (SII), the company manufacturing Covishield -- the local version of the Oxford–AstraZeneca COVID-19 vaccine, has sought indemnity protection against liabilities, news agency ANI reported quoting sources.

Serum Institute of India (SII), the company manufacturing Covishield -- the local version of the Oxford–AstraZeneca COVID-19 vaccine, has sought indemnity protection against liabilities, news agency ANI reported quoting sources. June 03, 2021 at 10:06AM https://ift.tt/3pjfv7E
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)